The University of Liège wishes to use cookies or trackers to store and access your personal data, to perform audience measurement. Some cookies are necessary for the website to function. Cookie policy.
![]() ![]() | Hubaux, R., Vandermeers, F., Cosse, J.-P., Crisanti, C., Kapoor, V., Albelda, S. M., Mascaux, C., Delvenne, P., Hubert, P., & Willems, L. (19 October 2015). Valproic acid improves second-line regimen of small cell lung carcinoma in preclinical models. ERJ Open Research, 1 (2), 00028. doi:10.1183/23120541.00028-2015 ![]() |
![]() ![]() | Gillet, N., Vandermeers, F., De Brogniez, A., Florins, A., Nigro, A., François, C., Bouzar, A.-B., Verlaeten, O., Stern, E., Lambert, D., Wouters, J., & Willems, L. (2012). Chemoresistance to Valproate Treatment of Bovine Leukemia Virus-Infected Sheep; Identification of Improved HDAC Inhibitors. Pathogens, (2012-1), 65-82. doi:10.3390/pathogens1020065 ![]() |
![]() ![]() | Hubaux, R., Vandermeers, F., Crisanti, C., Kapoor, V., Burny, A., Mascaux, C., Albelda, S. M., & Willems, L. (09 June 2010). Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy. European Journal of Cancer, 46, 1724-1734. doi:10.1016/j.ejca.2010.03.021 ![]() |
![]() ![]() | Crisanti, C., Wallace, A., Kapoor, V., Vandermeers, F., Dowling, M., Pereira, L., Coleman, K., Campling, B., Fridlender, Z., Kao, G., & Albelda, S. (August 2009). The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer. Molecular Cancer Therapeutics, 8 (8), 2221-2231. doi:10.1158/1535-7163.MCT-09-0138 ![]() |
![]() ![]() | Vandermeers, F., Hubert, P., Delvenne, P., Mascaux, C., Grigoriu, B., Burny, A., Scherpereel, A., & Willems, L. (2009). Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma. Clinical Cancer Research, 15 (8), 2818-28. doi:10.1158/1078-0432.CCR-08-1579 ![]() |
![]() ![]() | Vandermeers, F., Kettmann, R., & Willems, L. (2008). Implication des modifications épigénétiques dans les cancers : développement de nouvelles approches thérapeutiques. Biotechnologie, Agronomie, Société et Environnement, 12 (2). ![]() |
![]() ![]() | Florins, A.-F., Boxus, M., Vandermeers, F., Verlaeten, O., Bouzar, A., Defoiche, J., Hubaux, R., Burny, A., Kettmann, R., & Willems, L. (2008). Emphasis on cell turnover in two hosts infected by bovine leukemia virus: a rationale for host susceptibility to disease. Veterinary Immunology and Immunopathology, 125 (1-2), 1-7. doi:10.1016/j.vetimm.2008.04.007 ![]() |
![]() ![]() | Gillet, N., Florins, A.-F., Boxus, M., Burteau, C., Nigro, A., Vandermeers, F., Balon, H., Bouzar, A., Defoiche, J., Burny, A., Reichert, M., Kettmann, R., & Willems, L. (2007). Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology, 4 (1), 18. doi:10.1186/1742-4690-4-18 ![]() |
![]() ![]() | Florins, A.-F., Gillet, N., Asquith, B., Boxus, M., Burteaux, C., Twizere, J.-C., Urbain, P., Vandermeers, F., Debacq, C., Sanchez-alcaraz, M. T., Schwartz-Cornil, I., Kerkhofs, P., Jean, G., Thewis, A., Hay, J., Mortreux, F., Wattel, E., Reichert, M., Burny, A., ... Willems, L. (2007). Cell dynamics and immune response to BLV infection: a unifying model. Frontiers in Bioscience-Landmark, 12, 1520-1531. doi:10.2741/2165 ![]() |
![]() ![]() | Florins, A.-F., Gillet, N., Boxus, M., Verlaeten, O., Nigro, A., Vandermeers, F., Burteau, C., Balon, H., Bouzar, A., Defoiche, J., Burny, A., Kettmann, R., & Willems, L. (2007). Dynamique cellulaire de la pathogenèse induite par le virus de la leucémie bovine. Virologie. doi:10.1684/vir.2007.0134 ![]() |
![]() ![]() | Achachi, A.* , Florins, A.-F.* , Gillet, N.* , Debacq, C., Urbain, P., Foutsop, G. M., Vandermeers, F., Jasik, A., Reichert, M., Kerkhofs, P., Lagneaux, L., Burny, A., Kettmann, R., & Willems, L. (2005). Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo. Proceedings of the National Academy of Sciences of the United States of America, 102 (29), 10309-14. doi:10.1073/pnas.0504248102 ![]() * These authors have contributed equally to this work. |